Details

Autor(en) / Beteiligte

• Leung, Alexander A., MD MPH
• Nerenberg, Kara, MD MSc
• Daskalopoulou, Stella S., MD PhD
• McBrien, Kerry, MD MPH
• Zarnke, Kelly B., MD MSc
• Dasgupta, Kaberi, MD MSc
• Cloutier, Lyne, RN PhD
• Gelfer, Mark, MD
• Lamarre-Cliche, Maxime, MD
• Milot, Alain, MD MSc MD
• Bolli, Peter, MD
• Tremblay, Guy, MD
• McLean, Donna, RN NP PhD
• Tobe, Sheldon W., MD MSc(HPTE)
• Ruzicka, Marcel, MD PhD
• Burns, Kevin D., MD
• Vallée, Michel, MD PhD
• Ramesh Prasad, G.V., MBBS MSc
• Lebel, Marcel, MD
• Feldman, Ross D., MD
• Selby, Peter, MBBS MHSc
• Pipe, Andrew, CM MD
• Schiffrin, Ernesto L., MD PhD
• McFarlane, Philip A., MD PhD
• Oh, Paul, MD
• Hegele, Robert A., MD
• Khara, Milan, MBChB
• Wilson, Thomas W., MD
• Penner, S. Brian, MD
• Burgess, Ellen, MD
• Herman, Robert J., MD
• Bacon, Simon L., PhD
• Rabkin, Simon W., MD
• Gilbert, Richard E., MD PhD
• Campbell, Tavis S., PhD
• Grover, Steven, MD MPA
• Honos, George, MD
• Lindsay, Patrice, RN PhD
• Hill, Michael D., MD MSc
• Coutts, Shelagh B., MD
• Gubitz, Gord, MD
• Campbell, Norman RC., MD
• Moe, Gordon W., MD MSc
• Howlett, Jonathan G., MD
• Boulanger, Jean-Martin, MD
• Prebtani, Ally, MD
• Larochelle, Pierre, MD
• Leiter, Lawrence A., MD
• Jones, Charlotte, MD PhD
• Ogilvie, Richard I., MD
• Woo, Vincent, MD
• Kaczorowski, Janusz, PhD
• Trudeau, Luc, MD
• Petrella, Robert J., MD PhD
• Hiremath, Swapnil, MD MPH
• Drouin, Denis, MD
• Lavoie, Kim L., PhD
• Hamet, Pavel, MD PhD
• Fodor, George, MD PhD
• Grégoire, Jean C., MD
• Lewanczuk, Richard, MD PhD
• Dresser, George K., MD PhD
• Sharma, Mukul, MD MSc
• Reid, Debra, PhD RD
• Lear, Scott A., PhD
• Moullec, Gregory, PhD
• Gupta, Milan, MD
• Magee, Laura A., MD MSc
• Logan, Alexander G., MD
• Harris, Kevin C., MD MHSc
• Dionne, Janis, MD
• Fournier, Anne, MD
• Benoit, Geneviève, MD
• Feber, Janusz, MD
• Poirier, Luc, BPharm MSc
• Padwal, Raj S., MD MSc
• Rabi, Doreen M., MD MSc

Titel

Hypertension Canada’s 2016 CHEP Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention and Treatment of Hypertension

Ist Teil von

• Canadian journal of cardiology, 2015

Erscheinungsjahr

2015

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Abstract Hypertension Canada's CHEP Guidelines Task Force provides annually-updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present four new recommendations, as well as revisions to two previous recommendations. In the diagnosis and assessment of hypertension, automated office blood pressure, taken without patient-health provider interaction, is now recommended as the preferred method of measuring in-office blood pressure. Also, while a serum lipid panel remains part of the routine laboratory testing for patients with hypertension, both fasting and non-fasting collections are now considered acceptable. For individuals with secondary hypertension arising from primary hyperaldosteronism, adrenal vein sampling is recommended for those who are candidates for potential adrenalectomy. With respect to the treatment of hypertension, a new recommendation that has been added is for increasing dietary potassium to reduce blood pressure in those who are not at high risk for hyperkalemia. Furthermore, in selected high-risk patients, intensive blood pressure reduction to a target systolic blood pressure ≤120 mmHg should be considered to lower the risk of cardiovascular events. Finally, in hypertensive individuals with uncomplicated, stable angina pectoris, either a β blocker or calcium channel blocker may be considered for initial therapy. The specific evidence and rationale underlying each of these recommendations are discussed. Hypertension Canada's CHEP Guidelines Task Force will continue to provide annual updates.